T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: A case study

Clinical Immunology

Volumn 119, Issue 1, 2006, Pages 79-86

  Gallot, Géraldine ^a   Hamidou, Mohamed A ^b   Clémenceau, Béatrice ^a   Gaschet, Joëlle ^a   Tiberghien, Pierre ^c   Ferrand, Christophe ^a   Vivien, Régine ^a   Barbarot, Sébastien ^b   Coste Burel, Marianne ^b   Moreau, Anne ^b   Vié, Henri ^a,b  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c EFS Franche Comté Besancon ^*

Author keywords

CAEBV; Clonal expansion; CTL; EBV; T repertoire

Indexed keywords

ADULT; ANIMAL CELL; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELLULAR IMMUNITY; EPSTEIN BARR VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; LABORATORY TEST; LYMPHOBLASTOID CELL LINE; LYMPHOCYTIC INFILTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MEMORY T LYMPHOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN DISEASE; T LYMPHOCYTE SUBPOPULATION; VASCULITIS;

ADULT; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL SEPARATION; CERCOPITHECUS AETHIOPS; CHRONIC DISEASE; COCULTURE TECHNIQUES; COMPLEMENTARITY DETERMINING REGIONS; COS CELLS; CYTOTOXICITY, IMMUNOLOGIC; DNA, VIRAL; EPITOPES, T-LYMPHOCYTE; EPSTEIN-BARR VIRUS INFECTIONS; GENES, MHC CLASS I; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOPROLIFERATIVE DISORDERS; MALE; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SKIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS; VIRAL PROTEINS;

EID: 33644772004     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2005.11.008     Document Type: Article

References (28)

1. S.E. Straus The chronic mononucleosis syndrome J. Infect. Dis. 157 1988 405 412
2. M. Okano, S. Matsumoto, T. Osato, Y. Sakiyama, G.M. Thiele, and D.T. Purtilo Severe chronic active Epstein-Barr virus infection syndrome Clin. Microbiol. Rev. 4 1991 129 135
3. H. Kikuta, Y. Taguchi, K. Tomizawa, K. Kojima, N. Kawamura, A. Ishizaka, Y. Sakiyama, S. Matsumoto, S. Imai, and T. Kinoshita Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease Nature 333 1988 455 457
4. S. Ishihara, A. Tawa, K. Yumura-Yagi, M. Murata, J. Hara, H. Yabuuchi, K. Hirai, and K. Kawa-Ha Clonal T cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection Jpn. J. Cancer Res. 80 1989 99 101
5. K. Kawa-Ha, S. Ishihara, T. Ninomiya, K. Yumara-Yagi, J. Hara, F. Murayama, A. Tawa, and K. Hirai CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA J. Clin. Invest. 84 1989 51 55
6. Y. Fukunaga, T. Asano, J. Takehana, K. Ambo, K. Matsuoka, and M. Yamamoto CD3-negative lymphoproliferative disease of granular lymphocytes in a girl with an unusual pattern of anti-Epstein-Barr virus antibodies Eur. J. Pediatr. 153 1994 894 897
7. H. Kanegane, T. Wado, K. Nunogami, H. Seki, N. Taniguchi, and G. Tosato Chronic persistent Epstein-Barr virus infection of natural killer cells and B cells associated with granular lymphocytes expansion Br. J. Haematol. 95 1996 116 122
8. H. Kanegane, K. Bhatia, M. Gutierrez, H. Kaneda, T. Wada, A. Yachie, H. Seki, T. Arai, S. Kagimoto, M. Osazaki, T. Oh-ishi, A. Moghaddam, F. Wang, and G. Tosato A syndrome of peripheral blood T cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T cell lymphoma Blood 91 1998 2085 2091
9. A. Nakagawa, M. Ito, and S. Saga Fatal cytotoxic T cell proliferation in chronic active Epstein-Barr virus infection in childhood Am. J. Clin. Pathol. 117 2002 283 290
10. S. Hauptmann, N. Meru, C. Schewe, A. Jung, F. Hiepe, G. Burmester, G. Niedobidek, and F. Buttgereit Fatal atypical T cell proliferation associated with Epstein-Barr virus infection Br. J. Haematol. 112 2001 377 380
11. S. Ohga, N. Kimura, H. Takada, M. Nagano, K. Oshima, A. Nomura, K. Muraoka, H. Take, S. Yamamori, and T. Hara Restricted diversification of T cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease Am. J. Hematol. 61 1999 26 33
12. L. Quintanilla-Martinez, S. Kumar, F. Fend, E. Reyes, J. Teruya-Feldstein, D.W. Kingma, L. Sorbara, M. Raffeld, S.E. Strauss, and E.S. Jaffe Fulminant EBV(+) T cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome Blood 15 2000 443 451
13. J.M. Berthelot, X. Saulquin, M. Coste-Burel, M.A. Peyrat, K. Echasserieau, M. Bonneville, and E. Houssaint Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: a 15 month followup pilot study J. Rheumatol. 30 2003 1673 1679
14. H.G. Niesters, J. van Esser, E. Fries, K.C. Wolthers, J. Cornelissen, and A.D. Osterhaus Development of a real-time quantitative assay for detection of Epstein-Barr virus J. Clin. Microbiol. 38 2000 712 715
15. C. Ibisch, X. Saulquin, G. Gallot, R. Vivien, C. Ferrand, P. Tieberghien, E. Houssaint, and H. Vié The T cell repertoire selected in vitro against EBV: diversity, specificity, and improved purification through early IL-2 receptor alpha-chain (CD25)-positive selection J. Immunol. 164 2000 4924 4932
16. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
17. T.I. Bonner, S.B. Kerby, P. Sutrave, M.A. Gunnell, G. Mark, and U.R. Rapp Structure and biological activity of human homologs of the raf/mil oncogene Mol. Cell. Biol. 5 1985 1400 1407
18. I. Puisieux, C. Bain, Y. Merrouche, P. Malacher, P. Kourilsky, J. Even, and M. Favrot Restriction of the T cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T cell expansions Int. J. Cancer 66 1996 201 208
19. C. Pannetier, J. Even, and P. Kourilsky T cell repertoire diversity and clonal expansions in normal and clinical samples Immunol. Today 16 1995 176 181
20. E. Scotet, J. David-Ameline, M.A. Peyrat, A. Moreau-Aubry, D. Pinczon, A. Lim, J. Even, G. Semana, J.M. Berthelot, and R. Breathnach T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis J. Exp. Med. 184 1996 1791 1800
21. E. Scotet, M.A. Peyrat, X. Saulquin, C. Retiere, C. Couedel, F. Davodeau, N. Dulphy, A. Toubert, J.D. Bignon, and A. Lim Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes Eur. J. Immunol. 29 1999 973 985
22. V. Brichard, A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J. Exp. Med. 178 1993 489 495
23. T. Espevik, and J. Nissen-Meyer A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes J. Immunol. Methods 95 1986 99 105
24. C. Grosieux, J.C. Amoric, F. Mechinaud, A. Moreau, J.M. Mussini, H. Fesneau, B. Dreno, B. Bureau, J.F. Stadler, and P. Litaoux Cutaneous and neurologic vasculitis disclosing EBV-selective immunodeficiency Ann. Dermatol. Venereol. 123 1996 387 392
25. B. Savoldo, M.H. Huls, Z. Liu, T. Okamura, H.D. Volk, P. Reinke, R. Sabat, N. Babel, J.F. Jones, J. Webster-Cyriaque, A.P. Gee, M.K. Brenner, H.E. Heslop, and C.M. Rooney Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection Blood 100 2002 4059 4066
26. E. Houssaint, X. Saulquin, E. Scotet, and M. Bonneville Immunodominant CD8 T cell response to Epstein-Barr virus Biomed. Pharmacother. 55 2001 373 380
27. N.M. Steven, N.E. Annels, A. Kumar, A.M. Leese, M.G. Kurilla, and A.B. Rickinson Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response J. Exp. Med. 185 1997 1605 1617
28. B. Savoldo, M.H. Huls, Z. Liu, T. Okamura, H.D. Volk, P. Reinke, R. Sabat, N. Babel, J.F. Jones, and J. Webster-Cyriaque Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection Blood 100 2002 4059 4066